These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 25711464

  • 1. Iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions.
    Pack-Mabien A, Brown B, Herbert DE, Haynes J.
    J Am Assoc Nurse Pract; 2015 Oct; 27(10):591-6. PubMed ID: 25711464
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease.
    Ballas SK.
    Semin Hematol; 2001 Jan; 38(1 Suppl 1):30-6. PubMed ID: 11206959
    [Abstract] [Full Text] [Related]

  • 4. Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.
    Fung EB, Harmatz PR, Milet M, Balasa V, Ballas SK, Casella JF, Hilliard L, Kutlar A, McClain KL, Olivieri NF, Porter JB, Vichinsky EP, Multi-Center Iron Overload Research Group.
    Transfusion; 2008 Sep; 48(9):1971-80. PubMed ID: 18513257
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: results from ASIMILA study.
    Cancado R, Watman NP, Lobo C, Chona Z, Manzur F, Traina F, Park M, Drelichman G, Zarate JP, Marfil L.
    Hematology; 2018 Oct; 23(9):676-682. PubMed ID: 29663858
    [Abstract] [Full Text] [Related]

  • 7. Consequences and management of iron overload in sickle cell disease.
    Porter J, Garbowski M.
    Hematology Am Soc Hematol Educ Program; 2013 Oct; 2013():447-56. PubMed ID: 24319218
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Iron overload in sickle cell anemia : a study of 94 patients].
    Hafsia R, Belakhal F, Ben Salah N, Gouider E, Elborgi W.
    Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients.
    Fasano RM, Leong T, Kaushal M, Sagiv E, Luban NL, Meier ER.
    Transfusion; 2016 Jul; 56(7):1707-15. PubMed ID: 26997031
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M, Ou P, Elie C, Canniffe C, Kutty S, Delos V, Graffigne C, de Montalembert M, Brousse V.
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP).
    Files B, Brambilla D, Kutlar A, Miller S, Vichinsky E, Wang W, Granger S, Adams RJ.
    J Pediatr Hematol Oncol; 2002 May; 24(4):284-90. PubMed ID: 11972097
    [Abstract] [Full Text] [Related]

  • 15. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
    Woods D, Hayashi RJ, Binkley MM, Sparks GW, Hulbert ML.
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
    [Abstract] [Full Text] [Related]

  • 16. Comparison of serial serum ferritin measurements and liver iron concentration assessed by MRI in adult transfused patients with sickle cell disease.
    Tsitsikas DA, Nzouakou R, Ameen V, Sirigireddy B, Amos RJ.
    Eur J Haematol; 2014 Feb; 92(2):164-7. PubMed ID: 24175986
    [Abstract] [Full Text] [Related]

  • 17. Myocardial Iron Overload in Sickle Cell Disease: A Rare But Potentially Fatal Complication of Transfusion.
    Tavares AHJ, Benites BD, Fertrin KY.
    Transfus Med Rev; 2019 Jul; 33(3):170-175. PubMed ID: 31153715
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients.
    Hilliard LM, Williams BF, Lounsbury AE, Howard TH.
    Am J Hematol; 1998 Sep; 59(1):28-35. PubMed ID: 9723573
    [Abstract] [Full Text] [Related]

  • 20. Glycosylated ferritin as an improved marker for post-transfusion iron overload.
    Ishihara A, Yamauchi T, Ikeda K, Fukuyoshi Y, Yokoyama T, Yonemura Y, Uchiba M, Matsui H.
    Int J Hematol; 2021 Apr; 113(4):537-546. PubMed ID: 33400141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.